Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 EP256 | DOI: 10.1530/endoabs.90.EP256

ECE2023 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (355 abstracts)

Influence of diabetes mellitus on changes in preperitoneal fat measured by nutritional ultrasound, in a cohort of patients who required intensive care unit (ICU) admittance due to severe covid-19 pneumonia, during a 6-month follow-up program

Víctor José Simón Frapolli 1 , Isabel Vegas Aguilar 1 , Victoria González Rosa 2 , Ana María Sánchez García 3 , Francisco José Tinahones Madueño 1 & José Manuel García Almeida 1


1Hospital Universitario Virgen de la Victoria, Endocrinology and Nutrition, Málaga, Spain; 2Complejo Hospitalario Universitario Insular Materno Infantil, Endocrinology and Nutrition, Las Palmas de Gran Canaria, Spain; 3Hospital Universitario Virgen de la Victoria, Intensive Care Unit, Málaga, Spain


Introduction and Objectives: Preperitoneal fat is an ectopic visceral adipose tissue with a significant proinflammatory metabolic impact. The objective of this study is to measure preperitoneal fat by nutritional ultrasound at discharge, 3 months and 6 months in a cohort of patients who required admission to the Intensive Care Unit (ICU) due to severe COVID-19 pneumonia, and to analyze the differences based on the presence or not of previous DM.

Material and Method: Complete morphofunctional assessment was performed on 76 patients who were admitted to the ICU due to severe COVID-19 pneumonia, at discharge, 3 months and 6 months. Subsequently, preperitoneal fat measured by nutritional ultrasound was compared between diabetic and non-diabetic patients, using ANOVA for paired data (corrected by the Bonferroni test).

Results: Prospective observational study including 76 patients, 22 diabetics and 54 non-diabetics.

Table 1 Severity of Acute COVID-19 by Serum Glucose Levels and BMI
Baseline3 months6 monthsGlobal P (a,b,c)
Preperitoneal fat (non-DM) (cm)0.856(0.5)0.671(0.5)0.469(0.3)0.011 (0.056,0.092,1.000)
Preperitoneal fat (DM) (cm)0.503(0.3)0.469(0.3)0.538(0.4)0.859(0.848,0.975,1.000)
a=statistical significance baseline-3 months (P<0.05).b=statistical significance baseline-6 months (P<0.05).c=statistical significance 3 months-6 months (P<0.05).

Conclusion: During follow-up, patients without diabetes present a statistically significant decrease in preperitoneal fat, probably related to the resolution of the intercurrent infection (decrease in CRP during follow-up). In contrast, in diabetic patients it remains constant with no differences during follow-up despite the progressive decrease in CRP, which may be related to the chronic metabolic impact produced by DM.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

Authors